Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Use of split peripheral blood stem cell harvests in myeloma identifies functional preservation of progenitor cells cryopreserved for several years and demonstrates no functional damage to the bone marrow microenvironment.

Watts MJ, Ings SJ, Dorman J, Rabin N, Linch DC.

Bone Marrow Transplant. 2018 Jun;53(6):764-765. doi: 10.1038/s41409-018-0121-9. Epub 2018 Feb 12. No abstract available.

PMID:
29434289
2.

Re-evaluation of progenitor thresholds and expectations for haematopoietic recovery based on an analysis of 810 autologous transplants: Implications for quality assurance.

Watts MJ, Ings SJ, Balsa C, Antonio A, Hack S, Linch DC.

Br J Haematol. 2016 Nov;175(4):673-676. doi: 10.1111/bjh.14276. Epub 2016 Aug 9.

PMID:
27507229
3.

Engraftment defect of cytokine-cultured adult human mobilized CD34(+) cells is related to reduced adhesion to bone marrow niche elements.

Kallinikou K, Anjos-Afonso F, Blundell MP, Ings SJ, Watts MJ, Thrasher AJ, Linch DC, Bonnet D, Yong KL.

Br J Haematol. 2012 Sep;158(6):778-87. doi: 10.1111/j.1365-2141.2012.09219.x. Epub 2012 Jul 23.

PMID:
22816563
4.

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

Bloor AJ, Thomson K, Chowdhry N, Verfuerth S, Ings SJ, Chakraverty R, Linch DC, Goldstone AH, Peggs KS, Mackinnon S.

Biol Blood Marrow Transplant. 2008 Jan;14(1):50-8.

5.
6.

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects.

D'Sa S, Yong K, Kyriakou C, Bhattacharya S, Peggs KS, Foulkes B, Watts MJ, Ings SJ, Ardeshna KM, Goldstone AH, Williams CD.

Br J Haematol. 2004 Jun;125(6):756-65.

PMID:
15180865
7.

Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model.

Ahmed F, Ings SJ, Pizzey AR, Blundell MP, Thrasher AJ, Ye HT, Fahey A, Linch DC, Yong KL.

Blood. 2004 Mar 15;103(6):2079-87. Epub 2003 Nov 20.

PMID:
14630817
8.

The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.

Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R, Craddock CF, Linch DC, Solomon E.

Cancer Res. 2002 Aug 15;62(16):4730-5.

9.

Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices.

Watts MJ, Somervaille TC, Ings SJ, Ahmed F, Khwaja A, Yong K, Linch DC.

Br J Haematol. 2002 Jul;118(1):117-23.

PMID:
12100134
10.

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation.

Chakraverty R, Robinson S, Peggs K, Kottaridis PD, Watts MJ, Ings SJ, Hale G, Waldmann H, Linch DC, Goldstone AH, Mackinnon S.

Bone Marrow Transplant. 2001 Nov;28(9):827-34.

11.

Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile.

Watts MJ, Ings SJ, Flynn M, Dodds D, Goldstone AH, Linch DC.

Br J Haematol. 2000 Oct;111(1):287-91.

PMID:
11091215
12.

A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34+ progenitors.

Ardeshna KM, Corney CP, Ings SJ, Watts MJ, Linch DC, Devereux S.

Vox Sang. 2000;79(1):46-52.

PMID:
10971214
13.
14.
15.

Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3beta compared with mobilized adult progenitor cells.

Yong K, Fahey A, Reeve L, Nicholls C, Thomas NS, Pizzey A, Ings SJ, Watts MJ, Linch DC.

Br J Haematol. 1999 Nov;107(2):441-9.

PMID:
10583238
16.

Optimal timing for collection of PBPC after glycosylated G-CSF administration.

Watts MJ, Addison I, Ings SJ, Long SG, Hartley S, Warrington S, Boyce M, Linch DC.

Bone Marrow Transplant. 1998 Feb;21(4):365-8.

17.

Storage of PBSC at -80 degrees C.

Watts MJ, Sullivan AM, Ings SJ, Barlow M, Devereux S, Goldstone AH, Linch DC.

Bone Marrow Transplant. 1998 Jan;21(1):111-2. No abstract available.

18.

Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column procedures.

Watts MJ, Sullivan AM, Ings SJ, Leverett D, Peniket AJ, Perry AR, Williams CD, Devereux S, Goldstone AH, Linch DC.

Bone Marrow Transplant. 1997 Jul;20(2):157-62.

Supplemental Content

Support Center